American Oriental Bioengineering (广西博科药业) was selected as one of the "Top 20 Most Competitive Public Pharmaceutical Companies in China." The honor came after American Oriental was chosen from 132 China public pharmaceutical companies. Criteria for the selection included the companies' management capabilities, brand recognition, financial strength, resource accessibility and quality of key team members. More details...

Stock Symbol: (NYSE: AOB)